Success Story: Without RFE! A Chinese Scientist Secures NIW Success with Premium Processing Service and Our Assistance
Client’s Testimonial:
“Wonderful! We made it! Thank you so much!”
On January 30th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: January 30th, 2025
Processing Time: 2 months, 9 days (Premium Processing Requested)
Case Summary:
NAILG recently secured the approval of an EB-2 National Interest Waiver (NIW) petition for a Ph.D. holder in pharmacognosy. At the time of filing, the client was advancing his proposed endeavor of developing state-of-the-art gene testing technologies to identify genetic markers associated with a wide range of human diseases. His work seeks to facilitate early disease diagnoses and enable the development of effective treatments and personalized medicine approaches, an area of research of clear substantial merit and national importance.
Research with Substantial Merit and National Importance
We demonstrated that our client’s research directly supports U.S. efforts to improve healthcare outcomes and strengthen biomedical innovation. By advancing genetic testing methods that enhance the precision of diagnosis and treatment, his work not only improves clinical efficiency but also reduces healthcare costs and enhances patient quality of life. With genetically based approaches recognized as critical to advancing medicine and supported by major federal initiatives, his contributions offer substantial benefit to both public health and the broader scientific community.
Evidence of Accomplishments
The petition highlighted the client’s strong record of achievement, including:
● 5 peer-reviewed journal articles, with 2 first-authored publications.
● 4 abstracts, including 1 first-authored.
● 526 citations to his published work, underscoring its wide influence in biomedical science.
● At least 41 peer reviews completed for leading journals, reflecting his recognized authority in the field.
His research has consistently been selected for publication in respected journals, and many of his works rank among the most highly cited in their respective years. These accomplishments affirm both the innovation and the impact of his contributions, with his methods and findings widely adopted by other researchers.
NIW Approval and Outlook
USCIS granted approval after recognizing the client’s significant accomplishments and the national importance of his proposed endeavor. With NAILG’s support, the petition successfully demonstrated that waiving the job offer and labor certification requirements is in the best interest of the United States. This approval enables him to continue advancing genetic testing technologies that will drive progress in precision medicine, improving healthcare outcomes and strengthening the nation’s leadership in biomedical innovation.

